Table 1. Target values for LDL-C, non-HDL-C, and ApoB100 in diabetic patients.

Legend: 1. In very high-risk patients with overt CVD, a lower LDL-C goal of <70 mg/dl (1.8 mmol/l) is an option. If drug-treated patients do not reach the above target, additional American Diabetes Association (ADA) recommendations are the reduction of LDL-C by 30-40% from baseline. Lowering TG to <150 mg/dl (1.7 mmol/l), and raising HDL-C to >40 mg/dl in men and >50 mg/dl in women are desirable [58]. 2. The primary therapeutic goal in relation to LDL-C is < 100 mg/dl (2.6 mmol/l) for those with DM without overt CVD [58]. 3. Non-HDL-C is a secondary target of therapy in patients with high serum triglycerides (≥ 200 mg/dl) [59]. 4. The target values for ApoB100 are <80 mg/dl (1.60 mmol/l) in DM patients with overt CVD and <90 mg/dl (1.8 mmol/l) in those without overt CVD [11].